Drug Type Small molecule drug |
Synonyms KC 12615, KC-12615, SLV-306 |
Target |
Action inhibitors |
Mechanism ECE inhibitors(Endothelin-converting enzyme 1 inhibitors), enkephalinase inhibitors(Neprilysin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H38N2O6 |
InChIKeyXMQODGUTLZXUGZ-RPBOFIJWSA-N |
CAS Registry182821-27-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | Italy | 01 Jul 2005 | |
Kidney Diseases | Phase 2 | Italy | 01 Jul 2005 | |
Hypertension | Phase 2 | Australia | 01 Dec 2004 | |
Hypertension | Phase 2 | Bulgaria | 01 Dec 2004 | |
Hypertension | Phase 2 | Denmark | 01 Dec 2004 | |
Hypertension | Phase 2 | Estonia | 01 Dec 2004 | |
Hypertension | Phase 2 | Germany | 01 Dec 2004 | |
Hypertension | Phase 2 | Hungary | 01 Dec 2004 | |
Hypertension | Phase 2 | Israel | 01 Dec 2004 | |
Hypertension | Phase 2 | Latvia | 01 Dec 2004 |